Business
VitalHub Closes $74.75 Million Bought Deal Public Offering with Full Exercise of Over-Allotment Option
Toronto, Ontario--(Newsfile Corp. - August 20, 2025) - Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (...

About this update from Vitalhub Corp.
[{"type":"text","content":"VitalHub Closes $74.75 Million Bought Deal Public Offering with Full Exercise of Over-Allotment OptionToronto, Ontario--(Newsfile Corp. - August 20, 2025) - Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the \"Company\" or \"VitalHub\") is pleased to announce that it has closed its previously announced bought deal offering pursuant to a press release dated August 15, 2025. A total of 5,885,828 common shares of VitalHub (the \"Common Shares\") were sold at a price of $12.70 per Common Share for total gross proceeds of approximately $74.75 million, which included the full exercise of the over-allotment option (the \"Offering\"). The Offering was conducted by a syndicate of underwriters co-led by Cormark Securities Inc. and National Bank Financial Inc. and included Canaccord Genuity Corp., Scotia Capital Inc., and TD Securities Inc. (collectively, the \"Underwriters\").The Common Shares were qualified for distribution by a prospectus supplement dated August 15, 2025 to the base shelf prospectus dated July 23, 2025, filed in the provinces of Ontario, British Columbia and Alberta. The Common Shares were also sold in the United States on a private placement basis pursuant to an exemption from the registration requirements of the United States Securities Act of 1933 (the \"U.S. Securities Act\").The Common Shares have been conditionally approved for listing on the Toronto Stock Exchange (\"TSX\"). The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the final approval of the TSX.The Company intends to use the net proceeds from the Offering for the Company's growth initiative, as further described in the prospectus supplement. The Company's growth initiative is focused on future acquisitions of third-party enterprises in the health care industry which provide synergistic opportunities for the Company. The securities offered in the Offering have not been, and will not be, registered under the U.S. Securities Act or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or any applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This news release shall not constitute an offer to sell or th...